Ricardo Valencia-Villalobos

Mexico City, DIF, Mexico

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Effectiveness of a digital health intervention on the supportive care needs and quality of life in Mexican patients with breast cancer: a randomized clinical trial.

Effectiveness of a digital health intervention on the supportive care needs and quality of life in Mexican patients with breast cancer: a randomized clinical trial.

Journal: BMC cancer

Published: December 09, 2025

Capivasertib plus paclitaxel as first-line treatment for metastatic triple-negative breast cancer: Results from the randomised, global phase III CAPItello-290 trial.

Capivasertib plus paclitaxel as first-line treatment for metastatic triple-negative breast cancer: Results from the randomised, global phase III CAPItello-290 trial.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: June 12, 2025

Olaparib as Treatment Versus Nonplatinum Chemotherapy in Patients With Platinum-Sensitive Relapsed Ovarian Cancer: Phase III SOLO3 Study Final Overall Survival Results.

Olaparib as Treatment Versus Nonplatinum Chemotherapy in Patients With Platinum-Sensitive Relapsed Ovarian Cancer: Phase III SOLO3 Study Final Overall Survival Results.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: December 12, 2024

The Effects of Nebivolol-Gefitinib-Loratadine Against Lung Cancer Cell Lines.

The Effects of Nebivolol-Gefitinib-Loratadine Against Lung Cancer Cell Lines.

Journal: In vivo (Athens, Greece)

Published: August 10, 2024

Addressing the unmet needs of women with breast cancer in Mexico: a non-randomised pilot study of the digital ePRO intervention.

Addressing the unmet needs of women with breast cancer in Mexico: a non-randomised pilot study of the digital ePRO intervention.

Journal: BMJ open

Published: June 22, 2024

IMpassion132 double-blind randomised phase III trial of chemotherapy with or without atezolizumab for early relapsing unresectable locally advanced or metastatic triple-negative breast cancer.

IMpassion132 double-blind randomised phase III trial of chemotherapy with or without atezolizumab for early relapsing unresectable locally advanced or metastatic triple-negative breast cancer.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: March 20, 2024

Navigating HER2-Low Testing in Invasive Breast Cancer: Update Recommendations for Pathologists.

Navigating HER2-Low Testing in Invasive Breast Cancer: Update Recommendations for Pathologists.

Journal: Journal of personalized medicine

Published: February 28, 2024

Advanced, recurrent, and persistent cervical cancer management: in the era of immunotherapy.

Advanced, recurrent, and persistent cervical cancer management: in the era of immunotherapy.

Journal: Frontiers in oncology

Published: February 27, 2024

Potential of Kalanchoe pinnata as a Cancer Treatment Adjuvant and an Epigenetic Regulator.

Potential of Kalanchoe pinnata as a Cancer Treatment Adjuvant and an Epigenetic Regulator.

Journal: Molecules (Basel, Switzerland)

Published: July 15, 2022

Recommendations on the pharmacological treatment of epithelial ovarian cancer in Mexico.

Recommendations on the pharmacological treatment of epithelial ovarian cancer in Mexico.

Journal: Gaceta medica de Mexico

Published: January 03, 2022

ADXS11-001 LM-LLO as specific immunotherapy in cervical cancer.

ADXS11-001 LM-LLO as specific immunotherapy in cervical cancer.

Journal: Human vaccines & immunotherapeutics

Published: April 01, 2021

Showing 1-11 of 11

Last Updated: 09/26/2026